BNGO

Bionano Genomics, Inc.

1.14 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Bionano Genomics, Inc. stock is up 44.3% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 May’s closed higher than April. 100% of analysts rate it a buy.

About Bionano Genomics, Inc.

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping. NxClinical offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics.